Issued Patents All Time
Showing 1–25 of 184 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12415816 | Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof | Tinghu Zhang, Yao Liu, Mingfeng Hao, David Weinstock, Loretta Sze-Mun Li | 2025-09-16 |
| 12410194 | Potent and selective azaindole inhibitors of CDK8 and CDK19 | John Hatcher, Prasanna Sreevatsan | 2025-09-09 |
| 12398145 | Bicyclic urea kinase inhibitors and uses thereof | Yanke Liang, Hwan Geun Choi, Thomas Sundberg, Alykhan Shamji, Ramnik Xavier +2 more | 2025-08-26 |
| 12391671 | Allosteric EGFR inhibitors and methods of use thereof | David A. Scott, David Heppner, Thomas Gero, Courtney A. Cullis, Ciric To +5 more | 2025-08-19 |
| 12377080 | Allosteric EGFR inhibitors and methods of use thereof | Courtney A. Cullis, Krista E. Gipson, Yongbo Hu, Shih-Chung Huang, David A. Scott +5 more | 2025-08-05 |
| 12365696 | Small-molecule focal adhesion kinase (FAK) inhibitors | David A. Scott, Brian Groendyke, Behnam Nabet, Mikaela Mohardt | 2025-07-22 |
| 12365677 | Degraders that target proteins via KEAP1 | Tinghu Zhang, Eric Fischer, Guangyan Du, Nozhat Safaee, Nathaniel Henning +1 more | 2025-07-22 |
| 12365664 | Small molecule inhibitors of SRC tyrosine kinase | Guangyan Du, Tinghu Zhang, Nathaniel Henning, Suman Rao, Kenneth Dale Westover +1 more | 2025-07-22 |
| 12329821 | Degradation of bruton's tyrosine kinase (BTK) by conjugation of BTK inhibitors with E3 ligase ligand and methods of use | Dennis Dobrovolsky, Hai-Tsang Huang | 2025-06-17 |
| 12331037 | Pyrimidines as EGFR-inhibitors and methods of treating disorders | Pasi Janne, Hwan Geun Choi, Jaebong Jang | 2025-06-17 |
| 12325725 | Cyclin-dependent kinase degraders and methods of use | John Hatcher | 2025-06-10 |
| 12318452 | Degraders of WEE1 kinase | David A. Scott, Zhengnian Li, Benika J. Pinch, Calla M. Olson, Eric Fischer +2 more | 2025-06-03 |
| 12281126 | Inhibitors of cyclin-dependent kinase 7 and uses thereof | Tinghu Zhang, Nicholas Paul Kwiatkowski, Jie Jiang, Mingfeng Hao, Zhixiang He | 2025-04-22 |
| 12275731 | Azaindole inhibitors of wild-type and mutant forms of LRRK2 | John Hatcher, Jieun Choi, Hwangeun Choi, Eunhwa Ko, Namdoo Kim | 2025-04-15 |
| 12233128 | Degraders that target ALK and therapeutic uses thereof | John Hatcher, Chelsea E. Powell, Pasi Janne | 2025-02-25 |
| 12234220 | Immunomodulatory compounds | Tinghu Zhang, Eric Fischer, Alyssa Verano, Zhixiang He, Guangyan Du +4 more | 2025-02-25 |
| 12227488 | Small molecule degraders of Helios and methods of use | Alyssa Verano, Eric Wang, Radoslaw Nowak, Jing Yuan, Eric Fischer +2 more | 2025-02-18 |
| 12209076 | Imidazolyl kinase inhibitors and uses thereof | Hwan Geun Choi, Yanke Liang | 2025-01-28 |
| 12187701 | Taire family kinase inhibitors and uses thereof | Fleur M. Ferguson, Zainab M. Doctor | 2025-01-07 |
| 12168663 | Inhibitors of cyclin-dependent kinase 7 (CDK7) | Yanke Liang, Tinghu Zhang, Nicholas Paul Kwiatkowski | 2024-12-17 |
| 12161649 | Inhibitors of EGFR and methods of use thereof | Jaebong Jang, Dries De Clercq, David A. Scott | 2024-12-10 |
| 12157741 | Macrocyclic inhibitors of DYRK1A | John Hatcher, Hwangeun Choi | 2024-12-03 |
| 12157738 | Macrocyclic inhibitors of ALK, TRKA, TRKB, and ROS1 | John Hatcher | 2024-12-03 |
| 12123019 | Uses of kinase inhibitors for inducing and maintaining pluripotency | Thorold Theunissen, Rudolf Jaenisch | 2024-10-22 |
| 12121521 | Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis | Marc Wein, Henry M. Kronenberg, Thomas Sundberg, Ramnik Xavier, Yanke Liang +2 more | 2024-10-22 |